Expression and biological activity of porcine interleukin-18 in recombinant Lactococcus lactis

Shengwu Gongcheng Xuebao/Chinese Journal of Biotechnology

Volumn 30, Issue 10, 2014, Pages 1541-1548

  Ma, Lu ^a   Qiao, Xinyuan ^a   Tang, Lijie ^a   Jiang, Yanping ^a   Cui, Wen ^a   Li, Yijing ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

Author keywords

Biological activity; Lactococcus lactis; Porcine IL 18; Secretory expression

Indexed keywords

LACTOCOCCUS LACTIS; SUS;

INTERLEUKIN 18;

ANIMAL; BIOSYNTHESIS; ELECTROPORATION; GENE VECTOR; LACTOCOCCUS LACTIS; METABOLISM; PIG; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPORATION; GENETIC VECTORS; INTERLEUKIN-18; LACTOCOCCUS LACTIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE;

EID: 84911482897     PISSN: 10003061     EISSN: 18722075     Source Type: Journal    
DOI: 10.13345/j.cjb.140066     Document Type: Article

References (27)

1. Okamura H, Tsutsui H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature, 1995, 378(6552): 88-91.
2. Dao T, Ohashi K, Kayano T, et al. Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells. Cell Immunol, 1996, 173(2): 230.
3. Ushio S, Namba M, Okura T, et al. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol, 1996, 156(11): 4274-4279.
4. Sun WM, Wang HQ. Cell Factor Methodology. Beijing: People's Health Press, 1997: 536 (in Chinese).
5. Sun WC. Progress in the studies of Interleukin-18. Foreign Medical Science: Section of Clinic Biochemistry & Medical Test, 2000, 21(2): 57-59.
6. Tsutsui H, Nakanishi K, Matsui K, et al. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol, 1996, 157(9): 3967-3973.
7. Takeda K, Tsutsui H, Yoshimoto T, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity, 1998, Mar: 8(3): 383-390.
8. Chen JQ. 092 IL-18 and anti-tumor effects. Foreign Medical-Immunology Volume, 2000, 23(4): 239-243 (in Chinese).
9. Ogawa Y, Minagawa Y, Shi F, et al. Immunostimulatory effects of recombinant Erysipelothrix rhusiopathiae expressing porcine interleukin-18 in mice and pigs. Clin Vaccine Immunol, 2012, 19(9): 1393-1398.
10. Shao PF, Cui P, Zheng LL, et al. Construction of eukaryotic expression plasmid of porcine IL-18 gene and identification of bioactivity of its expressed protein. J Northwest A & F Univ Nat Sci Ed, 2009, 37(12): 85-90.
11. Chen HY, Zheng LL, Jin Y, et al. Expression of porcine IL-18 mature protein in Escherichia coli and identification of its bioactivity. J Mol Sci, 2009, 25(4): 284-289 (in Chinese).
12. Ravn P, Arnau J, Madsen SM, et al. The development of TnNuc and its use for the isolation of novel secretion signals in Lactococcus lactis. Gene, 2000, 242(1): 347-356.
13. Ravn P, Arnau J, Madsen SM, et al. Optimization of signal peptide SP310 for heterologous protein production in Lactococcus lactis. Microbiology, 2003, 149(8): 2193-2201.
14. Yin Z, Liu JH. Animal Virology. 2nd Edition. Beijing: Science Press, 1997: 631 (in Chinese).
15. Cao RB, Xu XQ, Zhou B, et al. Genetically modified and efficient prokaryotic expression of porcine interferon -α1. Chin J Biotech, 2004, 20(2): 291-294 (in Chinese).
16. Gu Y, Kuida K, Tsutsui H, et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science, 1997, 275(5297): 206-209.
17. Dinarello CA. Interleukin-18, a proinflammatory cytokine. European cytokine network, 2000, 11(3): 483-486.
18. Ni XL, Jin DY. Interleukin-18 research advances in cancer therapy. Outside the foreign branch of medical science, 2002, 29: 222-224 (in Chinese).
19. Kawakami K, Qureshi MH, Zhang T, et al. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol, 1997, 159(11): 5528-5534.
20. Kobayashi K, Nakata N, Kai M, et al. Decreased expression of cytokines that induce type 1 helper T cell/Interferon-γ responses in genetically susceptible mice infected with Mycobacterium avium. Clin Immunol Immunopathol, 1997, 85(1): 112-116.
21. Zhang T, Kawakami K, Qureshi MH, et al. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun, 1997, 65(9): 3594-3599.
22. Zheng M, Jin NY, Zhang YH, et al. The clone and its expression of porcine IL-18 mature protein gene in Escherichia coli. Chin J Vet Sci, 2003, 23: 430-432 (in Chinese).
23. Yuan HJ, Hu RL, Bao SJ, et al. Cloning and immunological characteristics of canine IL-18 cDNA. J Cell Mol Immunol, 2004, 20(5): 526-529 (in Chinese).
24. Pei JF, Chen RA, Tang XY, et al. The expression of porcine interleukin-18 gene and the purification of its recombinant protein. Chin J Vet Drug, 2007, 41(2): 5-9(in Chinese).
25. Brisson G, Britten M, Pouliot Y. Heat-induced aggregation of bovine lactoferrin at neutral pH: effect of iron saturation. Inter Dairy J, 2007, 17(6): 616-617.
26. Bohn E, Sing A, Zumbihl R, et al. IL-18 (IFN-γ-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol, 1998, 160(1): 299-307.
27. Guidotti LG. The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection. Vaccine, 2002, 20: A80-A82.